Tag Archives: mesothelioma diagnosis

Mesothelioma and MRI Scans: Using an Old Tool in a New Way

Mesothelioma and MRI Scans: Using an Old Tool in a New Way

Imaging scans are an important tool in helping clinicians diagnose mesothelioma. These scans include X-rays, CT scans, MRI scans, and PET scans. These tools help clinicians to see tumors inside a patient’s body. The results of the scan cannot diagnose mesothelioma, but it is an important tool for arriving at the correct diagnosis. Unlike X-rays and CT’s, magnetic resonance imaging (MRI) scans use a completely different type of radiation. An MRI applies a very strong magnetic field to change the spin of protons. The scanner also produces a radio frequency. This process produces a signal that can be made into an image. Until now, the role of MRIs has been limited in mesothelioma. However, new evidence suggests MRIs can be … Continue reading Mesothelioma and MRI Scans: Using an Old Tool in a New Way »

Mesothelioma Mimics Ovarian Cancer: Lessons from a Case Report

Mesothelioma Mimics Ovarian Cancer: Lessons from a Recent Case Report

Mesothelioma mimics ovarian cancer in a new report by Radiology Case Reports. Mesothelioma is a rare and very aggressive tumor of the peritoneum. Similar clinical and imaging presentations mean mesothelioma mimics ovarian cancer at times. Yet, a history of asbestosis exposure is key as the main risk factor for mesothelioma. Imaging plays a key role in getting the diagnosis correct. It narrows down the diagnosis possibilities. Ultrasound-guided biopsy with histological study can confirm a mesothelioma diagnosis. Case Report Misdiagnosis The Bangladesh National Institute of Oncology recently published a case report. A 42-year-old woman reported pelvic pain and progressive abdominal distension. An abdominal ultrasound revealed a high volume anechoic peritoneal effusion. Further investigation showed extensive peritoneal disease and bilateral ovarian tissue … Continue reading Mesothelioma Mimics Ovarian Cancer: Lessons from a Case Report »

Research Advancements Audit by Asbestos Diseases Research Institute

Research Advancements Audit by Asbestos Diseases Research Institute

Research advancements provide a brighter future for malignant pleural mesothelioma patients. Pleural mesothelioma is an aggressive cancer of the lung lining. Mesothelioma is associated with asbestos exposure. Australian researchers from the Asbestos Diseases Research Institute and the University of Sydney have reviewed the basic research advancements. Their new publication covers mesothelioma biomarkers and treatment strategies. There is a long latency period from asbestos exposure to cancer development. A lack of genetic biomarkers makes early diagnosis difficult. The prognosis of pleural mesothelioma is poor. There is an average survival of eight to fourteen months following diagnosis. Diagnostic Biomarkers Biomarkers are limited in the clinic to diagnose pleural mesothelioma. A biomarker is a biological molecule found in blood or other body fluids … Continue reading Research Advancements Audit by Asbestos Diseases Research Institute »

Detecting Mesothelioma by Smell: A Promising Future

Detecting Mesothelioma by Smell

Early cancer detection can be difficult, but there is a promising history of research on detecting mesothelioma by smell. A new study suggests that a change in a patient’s body odor may be used for early malignant pleural mesothelioma detection. This holds tremendous hope for early treatment. Right now, pleural mesothelioma detection relies heavily on various clinical tests. These tests often include radiography, CT, MRI, ultrasound, and biopsy. All of these technologies and methods are effective. However, several are invasive, expensive, time-consuming, or limited to large hospital settings. In an article in BBA – Reviews on Cancer, researchers explore how body odor can detect malignant pleural mesothelioma. The team says the research on detecting mesothelioma by smell is promising. Nevertheless, … Continue reading Detecting Mesothelioma by Smell: A Promising Future »

Cancer Biomarker Test Could Detect Mesothelioma Earlier

cancer biomarker test

A new cancer biomarker test that promises to identify cancer in patients with “non-specific symptoms” could be the key to detecting mesothelioma earlier.  Malignant mesothelioma is a deadly cancer caused by asbestos. The early symptoms of mesothelioma are usually vague and similar to other conditions. As a result, mesothelioma is frequently diagnosed in a late stage. But a cancer biomarker test developed in the UK could change that. The test looks for small molecules called metabolites in the blood. Its developers say it has the potential to find cancer earlier than other blood-based cancer tests.  Non-Specific Symptoms Make Mesothelioma a Diagnostic Challenge Mesothelioma is a rare cancer. It is most common in people who worked or lived around asbestos in … Continue reading Cancer Biomarker Test Could Detect Mesothelioma Earlier »

Could Lipids Hold the Key to Improving the Mesothelioma Diagnostic Process?

mesothelioma diagnostic process

A new Chinese report suggests that molecules called lipids could hold the key to improving the mesothelioma diagnostic process. Mesothelioma is rare and hard to treat. It is critical to diagnose it accurately and as early as possible for the best outcomes. But the mesothelioma diagnostic process can be complex and difficult.  The Chinese researchers compared the amounts and types of lipids in the blood of mesothelioma patients to those in the blood of healthy people. They discovered five lipids that were higher in the mesothelioma patients and 29 that were lower.  The information could help doctors refine the mesothelioma diagnostic process. It could also help them determine how a patient is doing on a particular treatment.  Lipids and the … Continue reading Could Lipids Hold the Key to Improving the Mesothelioma Diagnostic Process? »

New Cancer Blood Test: Could it Find Early Mesothelioma?

new cancer blood test

Researchers in England are testing a new cancer blood test that promises to reveal the presence of hard-to-find cancers like mesothelioma earlier. The country’s National Health Service will offer the test to 165,000 UK residents next year as part of a clinical trial.  “Early detection, particularly for hard to treat conditions like ovarian and pancreatic cancer, has the potential to save many lives,” NHS England’s’ chief executive Simon Stevens told The Guardian newspaper. “This promising blood test could therefore be a gamechanger in cancer care, helping thousands more people to get successful treatment.” If the trial of the new cancer blood test is successful, it could be available to help detect mesothelioma within a few years.  The Challenge of Identifying … Continue reading New Cancer Blood Test: Could it Find Early Mesothelioma? »

Scientists Say Machine Learning Could Help Diagnose Mesothelioma Earlier

machine leaning might help diagnose mesothelioma earlier

Researchers in Toronto say machine learning could help doctors diagnose mesothelioma earlier. Molecular geneticists at the University of Toronto teamed up with cancer and heart doctors to conduct the new research. The team collected data from hundreds of suspected mesothelioma cases and ran it through different statistical analysis programs. The goal was to see which one was best at determining who had pleural mesothelioma and who did not. The results revealed some important information – both about the machine learning tools and about how doctors might diagnose mesothelioma earlier, even without them. Why Doctors Need to Diagnose Mesothelioma Earlier Mesothelioma is almost always caused by asbestos exposure. In the first few years of the disease, there may be no mesothelioma … Continue reading Scientists Say Machine Learning Could Help Diagnose Mesothelioma Earlier »

A New Look at the Complex Process of Mesothelioma Diagnosis

Mesothelioma is not only a difficult cancer to treat. It’s also notoriously difficult to diagnose. Because there are no definitive biomarkers that can quickly reveal if a patient has this aggressive cancer, diagnosing mesothelioma typically involves a combination of different techniques. A new article in the Archives of Pathology and Laboratory Medicine highlights some of the most useful and important diagnostic tests for mesothelioma. Pathologists Qudsia Arif, MD, and Aliya Husain, MD, of the University of Chicago used peer-reviewed publications, text books, and consensus among their fellow pathologists to compile their recommendations. According to the report, among the possible diagnostic biomarkers for mesothelioma, four of the most reliable are the proteins calretinin, WT-1, cytokeratin 5/6, and podoplanin. These, say the … Continue reading A New Look at the Complex Process of Mesothelioma Diagnosis »

European Group Issues Updated Treatment Guidelines for Mesothelioma

physician and colleagues

A group of medical researchers has just released an updated set of clinical practice guidelines for treating patients with malignant pleural mesothelioma, one of the rarest and most treatment-resistant forms of cancer. The guidelines, released by the European Society for Medical Oncology and published in the newest issue of the Annals of Oncology, contain six sets of recommendations designed to support clinicians in the management of mesothelioma from diagnosis to treatment and follow-up. Recommendation for Mesothelioma Diagnosis The updated ESMO mesothelioma guidelines recommend that all patients undergo a thorough occupational history with emphasis on asbestos exposure and a CT scan of their chest. They also recommend that all patients with pleural thickening have a biopsy but do not recommend routine … Continue reading European Group Issues Updated Treatment Guidelines for Mesothelioma »